Clinical Trials on Graviditetskomplikationer, hematologisk

Total 15445 results

Hospices Civils de Lyon

Not yet recruiting

Hypnosis: a Path to Appeasement (HYCVA)

Hematologic Cancer
Sellas Life Sciences Group
Sellas Life Sciences Group

Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies

Hematologic Malignancies

United States, China
Eli Lilly and Company

Active, not recruiting

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Neoplasms, Hematologic

United States, Germany, Australia, Sweden, France, Spain, Italy, Austria, Canada
Bellicum Pharmaceuticals

Withdrawn

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

Hematologic Malignancies

United States
Spirita Oncology, LLC

Terminated

A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations

AML | MDS | CMML

United States
Amgen

Completed

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Hepatic Impairment | Solid Tumors | Hematologic Malignancies

United Kingdom, Netherlands, United States, France
M.D. Anderson Cancer Center

Completed

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Hematologic Malignancies

United States
Masonic Cancer Center, University of Minnesota

Completed

Safety of Romiplostim (Nplate®) Following UCBT

Hematologic Malignancies

United States
Rafic Farah, MD

Completed

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Lymphoma | Leukemia | Myelofibrosis | MDS

United States
National Cancer Institute (NCI)

Terminated

Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies

Unspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid Cancer

United States
University of Liege

Completed

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

Hematologic Malignancies

Belgium
McMaster University
Canadian Institutes of Health Research (CIHR); Genzyme, a Sanofi Company; The...

Unknown

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Hematologic Malignancies

Canada
Essenlix Corporation

Completed

Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

Hematologic Tests

United States
Rabin Medical Center

Withdrawn

Effect of Blood Harvesting and Administration at End of CPB on Coagulation Profile

Hematologic Changes

Israel
Ribe County Hospital

Completed

Risk Stratification in Acutely Admitted Medical Patients

Hematologic Tests

Denmark
Tarix Pharmaceuticals

Withdrawn

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Hematologic Malignancy | Cord Blood Transplant | Inherited Metabolic Disease

United States
University College, London
bluebird bio

Active, not recruiting

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant (ITREC)

Post-transplant Lymphoproliferative Disease | Transplant-Related Hematologic Malignancy

United Kingdom
Chinese University of Hong Kong

Completed

Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.

Depression | Quality of Life | Anxiety | Hematologic Malignancy

Ethiopia
Acibadem University
Medipol University

Completed

Effects of NMES and Exercise in Hematological Cancer

Muscle Weakness | Hematologic Malignancy

Turkey
Lorenza Scotti

Unknown

Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients (ONCO-AGING)

Solid Tumor | Elderly Patients | Hematologic Malignancies

Italy
Nanjing University of Traditional Chinese Medicine

Recruiting

Mindfulness-based Virtual Reality Intervention

Hematologic Neoplasms

China
University of Colorado, Denver

Completed

Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

Hematologic Neoplasms

United States
Arcispedale Santa Maria Nuova-IRCCS

Unknown

Early Palliative Care and Hematological Cancer Patients (EPC-EMA1)

Hematologic Neoplasms

Italy
Novartis Pharmaceuticals

Completed

Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator

Hematologic Neoplasms

Israel, United States, Netherlands, Spain
Università degli Studi di Brescia

Unknown

Intra-bone Cord Blood Transplantation

Hematologic Neoplasms

Italy
Seoul National University Hospital
Seoul National University

Unknown

Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT

Hematologic Neoplasms

Korea, Republic of
Inje University

Unknown

Biomarker Research for Personalized Medicine

Hematologic Neoplasms

Korea, Republic of
University Hospital, Basel, Switzerland
University of Basel; University Hospital, Zürich

Completed

Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation (PROVIVO)

Hematologic Neoplasms

Switzerland
Jazz Pharmaceuticals

Completed

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

Hematologic Neoplasms

United States
Pharmacyclics LLC.

Completed

Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients

Neoplasms | Hematologic Neoplasms

United States
National Cancer Institute, Slovakia
Slovak Academy of Sciences

Recruiting

Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation (SCTMICROBIOM)

Hematologic Neoplasms

Slovakia
University of Nebraska

Withdrawn

Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy

Hematologic Neoplasms
Janssen Research & Development, LLC
Bristol-Myers Squibb

Completed

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies

Hematologic Neoplasms

United States, Poland, Spain, Israel, Turkey, Australia
Institut Paoli-Calmettes

Active, not recruiting

Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients

Hematologic Neoplasms

France
Bayer

Completed

Phase I Trial of BAY1251152 for Advanced Blood Cancers

Hematologic Neoplasms

Spain, United States, Germany, United Kingdom
Xian-Janssen Pharmaceutical Ltd.

Terminated

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Hematologic Neoplasms

China
University of Calgary
The Canadian Blood and Marrow Transplant Group

Completed

Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units

Hematologic Neoplasms

Canada
Washington University School of Medicine

Completed

Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

Hematologic Neoplasms

United States
Esanex Inc.
Serenex, Inc.

Completed

Safety And Pharmacology Of SNX-5422 Mesylate In Subjects With Refractory Hematological Malignancies

Hematologic Neoplasms

United States
Hebei Senlang Biotechnology Inc., Ltd.
Tongji Hospital

Recruiting

To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors

19 and 22+ B Cell Hematologic Tumors | 19 and 20+ B Cell Hematologic Tumors

China
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University; Université Paris XII

Completed

Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion (ILD-Treg)

Hematologic Neoplasms | Relapse

France
Millennium Pharmaceuticals, Inc.

Completed

Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction

Advanced Solid Tumors | Hematologic Malignancies

United States
Merck Sharp & Dohme LLC

Not yet recruiting

A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01B/LIGHTBEAM-U01)

Neoplasm Metastasis
Assistance Publique - Hôpitaux de Paris

Recruiting

COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies (COVIDVAC OH)

Solid Tumor | Thoracic Cancer | Hematologic Malignancy | Cancer, Treatment-Related | Vaccine Response Impaired

France
Ciusss de L'Est de l'Île de Montréal
ExCellThera inc.; Stem Cell Network

Active, not recruiting

UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

Cord Blood Transplant | High Risk Hematologic Malignancy

Canada
University of Chicago

Completed

Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies

Lymphoma | Leukemia | Myeloma

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Sepsis | Septic Shock | Hematologic Malignancy | Tumor | Allogeneic Stem Cell Transplantation
University Malaysia Sarawak
University of Malaya

Completed

Single Session of 30-Minute Mindful Breathing in Reducing Fatigue

Fatigue | Hematologic Malignancy

Malaysia
Imperial College Healthcare NHS Trust

Completed

Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT)

Hematologic Malignancy | Graft Versus Host Disease | Allogeneic Stem Cell Transplant | Stem Cell Transplant Complications
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Hematopoietic and Lymphoid Cell Neoplasm | Non-Neoplastic Hematologic and Lymphocytic Disorder

United States

Clinical Trials on Graviditetskomplikationer, hematologisk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations